Implementation of WHO's Doing What Matters in Times of Stress in Dutch Small and Medium-sized Enterprises (SMEs)
Recruiting · NCT06979089 · Interventional (participants receive a specific treatment) · Lead sponsor: VU University of Amsterdam
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this cluster randomized controlled trial is to explore if mental health in Dutch small and medium-sized enterprises (SMEs) can be improved by the World Health Organization's online program Doing What Matters in Times of Stress (DWM). The main questions it aims to answer are: * Does DWM improve the mental health of employees working in Dutch SMEs? * Does DWM improve work-related outcomes in employees working in Dutch SMEs? * How can DWM be implemented at a large scale in Dutch SMEs? Researchers will compare two groups to see if the DWM program is effective. One group will receive the DWM program and Care-as-Usual (group 1), and the other group will receive Care-as-Usual only (group 2). Participants will: * Follow the online DWM program for 5 weeks (only group 1). * Take part in 6 telephone appointments with a facilitator (helper) that provides extra support to complete the program (only group 1). * Complete 3 sets of questionnaires. Each set of questionnaire takes about 15 minutes to be completed (group 1 and group 2).
Who can take part
Inclusion criteria
- SMEs):
- Having 10 to 250 employees
- Being located in the Netherlands
- In case of insufficient recruitment among SMEs, a mitigation strategy is to recruit public and non-profit organizations, and units of larger organizations, all employing between 10 and 250 employees.
- Inclusion Criteria (Individual participants):
- 18 years or older
- Having elevated levels of psychological distress (Kessler Psychological Distress Scale; K10 scores \> 15.9)
- Sufficient literacy and mastery (written and spoken) of one of the languages the DWM intervention is being delivered in (i.e., Dutch or English)
- Having access to an electronic device with internet access to follow the intervention
- Written informed consent before entering the study
Exclusion criteria
- Individual participants):
- Imminent suicide risk, or expressed acute needs or protection risks that require immediate follow-up
- Currently receiving specialized psychological treatment (e.g., EMDR or CBT) at the time of screening
- In case of current psychotropic medication use: being on an unstable dose for at least 2 months or a change in dosage over the past 2 months.
- Having participated in the preceding ASCEND trial as supervisor (see NCT ID: NCT06989398)
Where it is running
1 location listed.
- Vrije Universiteit Amsterdam - Amsterdam, North Holland, Netherlands